BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22545097)

  • 1. Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN.
    Majumder M; Tutunea-Fatan E; Xin X; Rodriguez-Torres M; Torres-Garcia J; Wiebe R; Timoshenko AV; Bhattacharjee RN; Chambers AF; Lala PK
    PLoS One; 2012; 7(4):e35094. PubMed ID: 22545097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1.
    Vlahakis NE; Young BA; Atakilit A; Sheppard D
    J Biol Chem; 2005 Feb; 280(6):4544-52. PubMed ID: 15590642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-α9β1 integrin-mediated signaling induces breast cancer growth and lymphatic metastasis via the recruitment of cancer-associated fibroblasts.
    Ota D; Kanayama M; Matsui Y; Ito K; Maeda N; Kutomi G; Hirata K; Torigoe T; Sato N; Takaoka A; Chambers AF; Morimoto J; Uede T
    J Mol Med (Berl); 2014 Dec; 92(12):1271-81. PubMed ID: 25099519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A practical and sensitive method of quantitating lymphangiogenesis in vivo.
    Majumder M; Xin X; Lala PK
    Lab Invest; 2013 Jul; 93(7):779-91. PubMed ID: 23711825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.
    Nandi P; Girish GV; Majumder M; Xin X; Tutunea-Fatan E; Lala PK
    BMC Cancer; 2017 Jan; 17(1):11. PubMed ID: 28056899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.
    Timoshenko AV; Rastogi S; Lala PK
    Br J Cancer; 2007 Oct; 97(8):1090-8. PubMed ID: 17912247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion.
    Allen MD; Vaziri R; Green M; Chelala C; Brentnall AR; Dreger S; Vallath S; Nitch-Smith H; Hayward J; Carpenter R; Holliday DL; Walker RA; Hart IR; Jones JL
    J Pathol; 2011 Apr; 223(5):646-58. PubMed ID: 21341269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
    Xiong Y; Liu Z; Zhao X; Ruan S; Zhang X; Wang S; Huang T
    Biomed Pharmacother; 2018 Oct; 106():1-7. PubMed ID: 29940537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer.
    Sun L; Duan J; Jiang Y; Wang L; Huang N; Lin L; Liao Y; Liao W
    Cancer Lett; 2015 Feb; 357(1):242-253. PubMed ID: 25444928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.
    Lala PK; Nandi P; Majumder M
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):369-384. PubMed ID: 29858743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes.
    Vantyghem SA; Allan AL; Postenka CO; Al-Katib W; Keeney M; Tuck AB; Chambers AF
    Clin Exp Metastasis; 2005; 22(4):351-61. PubMed ID: 16170671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis.
    Xu J; Chambers AF; Tuck AB; Rodenhiser DI
    Cancer Genet Cytogenet; 2008 Feb; 181(1):1-7. PubMed ID: 18262045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deguelin--an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model.
    Hu J; Ye H; Fu A; Chen X; Wang Y; Chen X; Ye X; Xiao W; Duan X; Wei Y; Chen L
    Int J Cancer; 2010 Nov; 127(10):2455-66. PubMed ID: 20162567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway.
    Hong H; Jiang L; Lin Y; He C; Zhu G; Du Q; Wang X; She F; Chen Y
    BMC Cancer; 2016 Mar; 16():240. PubMed ID: 26992854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition.
    Gupta SK; Oommen S; Aubry MC; Williams BP; Vlahakis NE
    Oncogene; 2013 Jan; 32(2):141-50. PubMed ID: 22370635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.